• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Experiments with Vi-negative strains of Salmonella typhi.伤寒沙门氏菌Vi阴性菌株的实验
Bull World Health Organ. 1960;23(1):47-52.
2
Vi-negative strains of Salmonella typhosa: attempts to induce W-V reversion and the use of non-Vi strains in evaluating typhoid vaccines.伤寒沙门氏菌Vi阴性菌株:诱导W-V逆转的尝试以及非Vi菌株在伤寒疫苗评估中的应用
J Bacteriol. 1962 Oct;84(4):747-53. doi: 10.1128/jb.84.4.747-753.1962.
3
Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.对口服伤寒沙门氏菌Ty21a疫苗和肠外Vi荚膜多糖伤寒疫苗同时接种的特异性和交叉反应性免疫应答。
Vaccine. 2015 Jan 9;33(3):451-8. doi: 10.1016/j.vaccine.2014.11.030. Epub 2014 Nov 26.
4
Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.Vi 多糖伤寒疫苗经注射引起的针对非伤寒沙门氏菌的交叉免疫反应。
Vaccine. 2014 Jan 23;32(5):544-51. doi: 10.1016/j.vaccine.2013.12.001. Epub 2013 Dec 14.
5
A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.一种包含PspA家族1和2的二价结合疫苗有潜力预防多种肺炎链球菌菌株和伤寒沙门氏菌。
Vaccine. 2015 Feb 4;33(6):783-8. doi: 10.1016/j.vaccine.2014.12.032. Epub 2014 Dec 26.
6
Vi Capsular Polysaccharide Produced by Recombinant Serovar Paratyphi A Confers Immunoprotection against Infection by Serovar Typhi.重组甲型副伤寒 Vi 荚膜多糖对伤寒血清型感染具有免疫保护作用。
Front Cell Infect Microbiol. 2017 Apr 24;7:135. doi: 10.3389/fcimb.2017.00135. eCollection 2017.
7
Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?口服伤寒活疫苗伤寒沙门氏菌 Ty21a- 一种针对非伤寒沙门氏菌的替代疫苗?
Vaccine. 2012 Nov 26;30(50):7238-45. doi: 10.1016/j.vaccine.2012.10.002. Epub 2012 Oct 17.
8
HETEROLOGOUS IMMUNITY AGAINST S. TYPHI BY VACCINES OF LIVING E. FREUNDII VI STRAINS ASSOCIATED WITH SALMONELLAE OF THE "D" GROUP.与“D”组沙门氏菌相关的弗氏艾氏菌VI株活疫苗对伤寒杆菌的异源免疫
Z Immunitats Allergieforsch. 1964 Jun;126:431-7.
9
Assay of typhoid vaccines with Salmonella typhosa-Salmonella typhimurium hybrids.用伤寒沙门氏菌-鼠伤寒沙门氏菌杂交菌株检测伤寒疫苗
Infect Immun. 1973 Jan;7(1):5-8. doi: 10.1128/iai.7.1.5-8.1973.
10
Ineffectiveness of Vi and chemically treated endotoxins as typhoid vaccines in mice challenged with a Salmonella typhosa-Salmonella typhimurium hybrid.Vi 及化学处理的内毒素作为伤寒疫苗,对受鼠伤寒沙门氏菌-伤寒沙门氏菌杂交菌株攻击的小鼠无效。
Infect Immun. 1975 Dec;12(6):1470-1. doi: 10.1128/iai.12.6.1470-1471.1975.

引用本文的文献

1
THE PRESENT STATUS OF FIELD AND LABORATORY STUDIES OF TYPHOID AND PARATYPHOID VACCINES WITH SPECIAL REFERENCE TO STUDIES SPONSORED BY WORLD HEALTH ORGANIZATION.伤寒和副伤寒疫苗的现场及实验室研究现状,特别提及世界卫生组织资助的研究
Bull World Health Organ. 1965;32(1):29-36.
2
INTERNATIONAL REFERENCE PREPARATIONS OF TYPHOID VACCINE. A REPORT ON INTERNATIONAL COLLABORATIVE LABORATORY STUDIES.伤寒疫苗国际参考制剂。国际协作实验室研究报告。
Bull World Health Organ. 1964;31(6):761-91.
3
Vi-negative strains of Salmonella typhosa: attempts to induce W-V reversion and the use of non-Vi strains in evaluating typhoid vaccines.伤寒沙门氏菌Vi阴性菌株:诱导W-V逆转的尝试以及非Vi菌株在伤寒疫苗评估中的应用
J Bacteriol. 1962 Oct;84(4):747-53. doi: 10.1128/jb.84.4.747-753.1962.
4
H antigen of Salmonella typhosa.伤寒沙门氏菌的H抗原。
J Bacteriol. 1961 Jun;81(6):924-32. doi: 10.1128/jb.81.6.924-932.1961.
5
[Investigations on the evaluation of typhoid vaccines tested in British Guiana and Yugoslavia].[对在英属圭亚那和南斯拉夫测试的伤寒疫苗的评估调查]
Z Hyg Infektionskr. 1965;150(4):290-9.
6
A controlled field trial and laboratory study of five typhoid vaccines in the USSR.苏联对五种伤寒疫苗进行的对照现场试验和实验室研究。
Bull World Health Organ. 1966;34(3):321-39.

本文引用的文献

1
A STUDY OF THE DISSOCIATION OF THE RAWLINS STRAIN OF BACTERIUM TYPHOSUM WITH SPECIAL REFERENCE TO ITS USE IN THE PRODUCTION OF ANTI-TYPHOID VACCINE.伤寒杆菌罗林斯株的解离研究,特别参考其在伤寒疫苗生产中的应用。
J Exp Med. 1932 Nov 30;56(6):907-18. doi: 10.1084/jem.56.6.907.
2
The relative significance of graded immunizing and challenge doses in measuring the potency of vaccines; a study of mouse protection by typhoid vaccine.分级免疫剂量和激发剂量在衡量疫苗效力方面的相对重要性;伤寒疫苗对小鼠保护作用的研究。
J Exp Med. 1949 Sep;90(3):233-53. doi: 10.1084/jem.90.3.233.
3
The preparation, testing and standardization of typhoid vaccine.伤寒疫苗的制备、检测与标准化
J Hyg (Lond). 1951 Jun-Sep;49(2-3):268-97. doi: 10.1017/s0022172400044156.
4
A laboratory comparison of United States and British army typhoid-paratyphoid vaccine.美国和英国军队伤寒-副伤寒疫苗的实验室比较
Am J Trop Med Hyg. 1951 Sep;31(5):535-51. doi: 10.4269/ajtmh.1951.s1-31.535.
5
Studies on the O antigen of Salmonella typhosa. II. Immunological properties of the purified antigen.伤寒沙门氏菌O抗原的研究。II. 纯化抗原的免疫学特性。
J Immunol. 1955 Jun;74(6):466-78.
6
Laboratory tests of typhoid vaccines used in a controlled field study.在一项对照现场研究中使用的伤寒疫苗的实验室检测。
Bull World Health Organ. 1959;20(6):1017-32.
7
Studies on intracerebral typhoid infection in mice. II. Immunological factors concerned in protection.小鼠脑内伤寒感染的研究。II. 与保护相关的免疫因素。
Br J Exp Pathol. 1957 Feb;38(1):25-34.
8
Stimulation of natural immunity to Escherichia coli infection: observations on mice.对大肠杆菌感染天然免疫的刺激:对小鼠的观察
Lancet. 1955 Jan 29;268(6857):232-4. doi: 10.1016/s0140-6736(55)90163-x.
9
The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.备解素系统与免疫。I. 一种新的血清蛋白——备解素的证实、分离及其在免疫现象中的作用。
Science. 1954 Aug 20;120(3112):279-85. doi: 10.1126/science.120.3112.279.

伤寒沙门氏菌Vi阴性菌株的实验

Experiments with Vi-negative strains of Salmonella typhi.

作者信息

STANDFAST A F

出版信息

Bull World Health Organ. 1960;23(1):47-52.

PMID:13833749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2555310/
Abstract

The immunological properties of a number of strains of Salmonella typhi were tested. One of these strains, although it did not contain the Vi antigen, was able to protect the mice against Vi-positive challenge when used as a vaccine for mice. The finding of a stable Vi-negative strain is important, as many strains, such as the classic O 901, revert to the Vi-positive state on a single mouse passage.Using the Vi-negative organism as challenge in eight assays of the vaccines used in the Yugoslav field studies at Osijek, the phenolized vaccine was shown to be about 10 times more potent than the alcoholized vaccine. Further laboratory tests in conjunction with field trials will be necessary to show if these results are significant.

摘要

对若干伤寒沙门氏菌菌株的免疫特性进行了测试。其中一个菌株,尽管它不含有Vi抗原,但当用作小鼠疫苗时,能够保护小鼠免受Vi阳性菌株的攻击。发现一种稳定的Vi阴性菌株很重要,因为许多菌株,如经典的O 901,在小鼠体内传代一次就会恢复为Vi阳性状态。在奥西耶克进行的南斯拉夫现场研究中,使用Vi阴性菌株对八种疫苗进行攻击试验,结果表明酚化疫苗的效力比醇化疫苗高约10倍。是否这些结果具有显著性,还需要进一步的实验室测试并结合现场试验来证明。